Lilly/Icos Cialis Trial In Benign Prostatic Hyperplasia To Start This Year
Executive Summary
Lilly/Icos hopes results from a Phase II trial evaluating Cialis in benign prostatic hyperplasia will help position the erectile dysfunction therapy as the "treatment of choice," Icos told investors May 3